US House letter to HHS regarding Kalderos and their new program called “340B Pay”. 340B Pay will uproot the current 340B cash flow model and Kalderos (on behalf of certain drug manufactures that contract with Kalderos) will be able to control the entire 340B replenishment model.
See letter attached.